Company intelligence / Profile preview

Secura Bio

Las Vegas/Henderson, Nevada, USAsecurabio.com ↗
Ownership
Private
Employees
~41
Development stage
Commercial
01

Overview

Secura Bio is an integrated biopharmaceutical company founded in 2019 that develops and commercializes innovative therapies primarily targeting oncology indications such as myeloma, leukemia, glioma, lymphoma, and rare cancers. The company has raised over $100M in funding and operates out of Las Vegas/Henderson, Nevada. Its pipeline includes small molecule therapeutics—particularly antineoplastic agents—and it holds patents related to experimental cancer drugs including HDAC inhibitors. The company’s business model centers around both late-stage clinical development and commercialization of life-changing medicines for patients with serious illnesses.

Therapeutic areas
OncologyRare Diseases
Modalities
Small molecules (notably antineoplastic agents and histone deacetylase inhibitors)Orphan drugs for oncology indications
Industry
Biotech
02

Drug pipeline

2 assets

duvelisib

Commercial
Indications
Chronic lymphocytic leukemia, Peripheral T-cell lymphoma

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Secura Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Secura Bio.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call